Ben Kim is a Partner at Playground Global where he helps identify the founders and companies that are revolutionizing engineered biology. At Playground, he has sourced and led investments into companies including Atomic AI, Infinimmune, Insamo, Outpace Bio, and Manifold Bio. Prior to Playground, Ben was a PhD graduate student and an NSF Fellow at Stanford University, where he studied Bioengineering and Biomedical Engineering.